Articles with public access mandates - J. Jack LeeLearn more
Not available anywhere: 9
Review
Expression of iron homeostasis proteins in the spinal cord in experimental autoimmune encephalomyelitis and their implications for iron accumulation
JG Zarruk, JL Berard, RP dos Santos, A Kroner, J Lee, P Arosio, S David
Neurobiology of Disease 81, 93-107, 2015
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Review
Preventive maintenance modeling for multi-component systems with considering stochastic failures and disassembly sequence
X Zhou, K Huang, L Xi, J Lee
Reliability Engineering & System Safety 142, 231-237, 2015
Mandates: National Natural Science Foundation of China
Review
Fabrication of thermally rearranged (TR) polybenzoxazole hollow fiber membranes with superior CO2/N2 separation performance
KT Woo, J Lee, G Dong, JS Kim, YS Do, WS Hung, KR Lee, G Barbieri, ...
Journal of Membrane Science 490, 129-138, 2015
Mandates: Government of Italy
Review
Separation of CO2 from humidified ternary gas mixtures using thermally rearranged polymeric membranes
M Cersosimo, A Brunetti, E Drioli, F Fiorino, G Dong, KT Woo, J Lee, ...
Journal of Membrane Science 492, 257-262, 2015
Mandates: Government of Italy
Review
The relationship between negative symptom subdomains and cognition
J Lim, SA Lee, M Lam, A Rapisarda, M Kraus, RSE Keefe, J Lee
Psychological Medicine 46 (10), 2169-2177, 2016
Mandates: National Medical Research Council, Singapore
Review
Baseline social amotivation predicts 1-year functioning in UHR subjects: A validation and prospective investigation
M Lam, NAA Rashid, SA Lee, J Lim, G Foussias, G Fervaha, S Ruhrman, ...
European Neuropsychopharmacology 25 (12), 2187-2196, 2015
Mandates: National Medical Research Council, Singapore, National Research Foundation …
Review
Anti-tumor effects of an engineered “killer” transfer RNA
D Zhou, J Lee, C Frankenberger, R Geslain, M Rosner, T Pan
Biochemical and Biophysical Research Communications 427 (1), 148-153, 2012
Mandates: US National Institutes of Health
Review
Two-stage marker-stratified clinical trial design in the presence of biomarker misclassification
Y Zang, J Jack Lee, Y Yuan
Journal of the Royal Statistical Society Series C: Applied Statistics 65 (4 …, 2016
Mandates: US National Institutes of Health
Review
Abstract A21: Tissue platinum concentration and tumor response in non-small cell lung cancer
ES Kim, G He, CW Chow, J Fujimoto, JJ Lee, N Kalhor, SG Swisher, ...
Clinical Cancer Research 18 (3_Supplement), A21-A21, 2012
Mandates: US National Institutes of Health
Available somewhere: 238
Review
Comprehensive genomic characterization of head and neck squamous cell carcinomas.
JJ Lee
Nature 517 (7536), 576-82, 2015
Mandates: US National Institutes of Health
Review
The BATTLE trial: personalizing therapy for lung cancer
ES Kim, RS Herbst, II Wistuba, JJ Lee, GR Blumenschein Jr, A Tsao, ...
Cancer discovery 1 (1), 44-53, 2011
Mandates: US National Institutes of Health
Review
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
J Zhang, J Fujimoto, J Zhang, DC Wedge, X Song, J Zhang, S Seth, ...
Science 346 (6206), 256-259, 2014
Mandates: US National Institutes of Health, Research Foundation (Flanders), Cancer …
Review
An epithelial–mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor …
LA Byers, L Diao, J Wang, P Saintigny, L Girard, M Peyton, L Shen, Y Fan, ...
Clinical cancer research 19 (1), 279-290, 2013
Mandates: US National Institutes of Health
Review
Dose escalation methods in phase I cancer clinical trials
C Le Tourneau, JJ Lee, LL Siu
JNCI: Journal of the National Cancer Institute 101 (10), 708-720, 2009
Mandates: US National Institutes of Health
Review
Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome
NT Ihle, LA Byers, ES Kim, P Saintigny, JJ Lee, GR Blumenschein, A Tsao, ...
Journal of the National Cancer Institute 104 (3), 228-239, 2012
Mandates: US National Institutes of Health
Review
PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies Harboring PIK3CA Mutations
F Janku, JJ Wheler, SN Westin, SL Moulder, A Naing, AM Tsimberidou, ...
Journal of clinical oncology 30 (8), 777-782, 2012
Mandates: US National Institutes of Health
Review
Impact of precision medicine in diverse cancers: a meta-analysis of phase II clinical trials
M Schwaederle, M Zhao, JJ Lee, AM Eggermont, RL Schilsky, ...
Journal of clinical oncology 33 (32), 3817-3825, 2015
Mandates: US National Institutes of Health
Review
Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy
A Pataer, N Kalhor, AM Correa, MG Raso, JJ Erasmus, ES Kim, ...
Journal of Thoracic Oncology 7 (5), 825-832, 2012
Mandates: US National Institutes of Health
Review
PIK3CA Mutation H1047R Is Associated with Response to PI3K/AKT/mTOR Signaling Pathway Inhibitors in Early-Phase Clinical Trials
F Janku, JJ Wheler, A Naing, GS Falchook, DS Hong, VM Stepanek, S Fu, ...
Cancer research 73 (1), 276-284, 2013
Mandates: US National Institutes of Health
Review
Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions
AS Tsao, D Liu, J Martin, X Tang, JJ Lee, AK El-Naggar, I Wistuba, ...
Cancer prevention research 2 (11), 931-941, 2009
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program